GlaxoSmithKline to stop paying doctors to promote its drugs

A no entry sign is pictured outside the GlaxoSmithKline building in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor
A no entry sign is pictured outside the GlaxoSmithKline building in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor

GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff – a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit.

Britain’s biggest drugmaker also said on Tuesday it would stop payments to healthcare professionals for attending medical conferences as it tries to persuade critics it is addressing conflicts of interest that could put commercial interests ahead of the best outcome for patients.

The move may force other companies to act, since the entire drugs industry has been under fire for aggressive marketing tactics in recent years.

“Where GSK leads we must hope that other companies will follow,” Fiona Godlee, editor of the British Medical Journal and an influential campaigner against undue industry influence in medical practice, told Reuters.

“But there is a long way to go if we are to truly to extricate medicine from commercial influence. Doctors and their societies have been too ready to compromise themselves.”

GlaxoSmithKline’s move comes amid a major bribery investigation in China, where police have accused it of funneling up to 3 billion yuan ($494 million) to travel agencies to facilitate bribes to boost its drug sales.

However, the company said the measures were not directly related to its Chinese problems and were rather part of a broad effort to improve transparency.

In the United States, the industry’s biggest market by far, many companies have run into conflicts over improper sales tactics and GSK reached a record $3-billion settlement with the U.S. government last year over charges that it provided misleading information on certain drugs.

A number of other firms have taken some steps to clean up their marketing practices and companies are being forced to disclose payments to doctors under U.S. healthcare law.

Similar laws requiring firms to make public the names of doctors they have paid will take effect in Europe from the start of 2016.

“This will undoubtedly change behavior and trigger a re-think of how some forms of continuing medical education are organized and funded,” said Richard Bergstrom, director general of the European Federation of Pharmaceutical Industries and Associations.

Shares in GSK, hit in recent months by its woes in China and a resulting fall in sales, slid 1.4 percent against a 0.3 percent dip on London’s blue-chip FTSE index.

Colin McLean, managing director at SVM Asset Management, who holds shares in drugmakers including Pfizer but not GSK, said he would welcome other firms following GSK’s lead.

“Given the problems Glaxo had in China, it is important for investors to understand, at a deeper level, just how incentives work through an organization,” he said.

SELF REGULATION

AstraZeneca said in 2011 it was scrapping payments for doctors to attend international congresses but others, until now, have not followed suit and GSK’s actions go further.

An AstraZeneca spokeswoman said on Tuesday it had tightened up practices in 2011 so that its actions could not be seen as an inducement for doctors to prescribe its products.

Officials at other major drug companies were not immediately available to comment.

Tim Reed, head of Health Action International, an Amsterdam-based non-government organization critical of Big Pharma, said the GSK move would increase the pressure on other companies.

“I think other companies will follow suit – but one of the biggest problems is that the industry persists in regulating itself,” he said. “The only way to properly control promotion is strong and enforced regulation by the state.”

GSK’s Chief Executive Andrew Witty said in a statement that his company’s actions were designed to ensure that patients’ interests always came first.

“We recognize that we have an important role to play in providing doctors with information about our medicines, but this must be done clearly, transparently and without any perception of conflict of interest,” he said.

The decision to stop payments to doctors for speaking about medicines during meetings with other prescribers marks a big shift for a global industry that has always relied heavily on the influence of experts in promoting products.

GSK said it aimed to implement this move and a related measure to end paying for doctors to attend medical conferences by the start of 2016.

The company currently spends some 50 million pounds ($82 million) a year on paying doctors to speak or attend conferences, according to estimates from industry sources.

U.S. MODEL

The change in payments to GSK’s sales representatives will be implemented faster, following a successful test-run in the United States, where payments have been decoupled from the number of prescriptions generated since 2011.

The policy of ending individual sales targets will now be rolled out globally. GSK said it planned to implement the new compensation system in all countries by early 2015.

Its U.S. ‘Patient First’ program bases pay for commercial staff on a mix of qualitative measures and the overall business performance, rather than the number of prescriptions generated.

The shift is pragmatic to a certain extent, since many decisions about which drugs to use are now taken centrally by big insurers and governments, based on cost-effectiveness measurements, rather than by individual doctors.

Vivienne Nathanson, head of science and ethics at the British Medical Association, said the approach made sense for patient care.

“It is pleasing to see a large pharmaceutical company like GlaxoSmithKline recognize that it can reduce the possibility of undue influence by rewarding employees for providing high-quality information and education for doctors rather than for their sales figures,” she said.

GSK will still pay fees to doctors carrying out company-sponsored clinical research, advisory activities and market research, which it said were essential in providing insights on specific diseases.



News
Entertainment
Sports
Lifestyle
Local

Mayor announces public housing improvements

Mayor Bill de Blasio spoke at the Lincoln Houses in East Harlem on Wednesday, calling for the scaffolding to come down at NYCHA complexes across…

National

Peter Theo Curtis: American released by Syrian militants…

An American writer freed this week from two years in the captivity of insurgents in Syria spoke briefly outside his family's Cambridge home Wednesday of…

Local

Bratton defends 'broken windows' work as NYPD support…

Sixty percent of those polled said they support the "broken windows" theory approach popularized by Commissioner Bratton since his first term in the 1990s.

Local

Transit changes for Labor Day weekend

The MTA is adding additional service Friday for New Yorkers getting out of the city for the long weekend. On Friday, Aug. 29, 27 additional…

Television

'So You Think You Can Dance' recap: Season…

Season 11’s top four dancers gave their final performances before America’s Favorite Dancers are announced next week.

Going Out

Things to do this week in NYC, Aug.…

MUSIC The Electric Zoo Festival Aug. 29-31, 1 p.m. Randall’s Island Park $99-$369, www.electriczoofestival.com The electronic music celebration returns for a fifth year, with 150,000 attendees…

Going Out

5 things to do this weekend in NYC

The Electric Zoo Festival Aug. 29-31, 1 p.m. Randall’s Island Park $99-$369, www.electriczoofestival.com The electronic music celebration returns for a fifth year, with 150,000 attendees expected. David Guetta,…

Music

The Handsome Family on 'True Detective' Emmy and…

When asked to describe The Handsome Family’s latest album, Rennie Sparks channels Rust Cohle of “True Detective.” “A strange problem that humans have is that…

NFL

Mario Manningham on the bubble as Giants play…

Former Super Bowl hero Mario Manningham hopes his second go-around with Big Blue doesn’t end with Saturday’s final cut day.

NFL

Source: Stephen Hill 'faces a battle' to make…

A team source says Stephen Hill, who has battled injuries and poor performances during his first two years, is no lock to make the Jets’ final roster.

Sports

Serena Williams leaving legacy of talented American women…

It seems only a matter of when, not if, Serena Williams will win her 18th career grand slam championship.

College

When are 2014 college football playoffs? (Schedule, date,…

When and where are 2014 college football playoffs? A look at the schedule, date, TV, time for the semi-finals at championship game.

Food

Recipe: Samuel Adams beer-marinated grilled shrimp

Summer calls for two things: a cold beer and light food. Sam Adams' Latitude 48 IPA fairly bursts with citrus notes, making it an ideal marinade…

Wellbeing

Heart trumps brain when it comes to movies…

When you need a good cry, do you reach for the movie that’s “based on a true story”? Science says you’re giving your brain far…

Sex

The 10 types of people you meet online

Does it ever seem like online dating profiles tend to get a little repetitive? It turns out you are not the only one to have…

Home

Labor Day essentials

Whether you’re soaking up the sun on the beach or barbecuing in the park here are some must-haves for your end-of-summer bash.